Accuracy of Current Techniques in Quantifying Ketone Levels
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of this study is to determine the accuracy of current measuring techniques used to detect physiological ketone levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2019
CompletedFirst Submitted
Initial submission to the registry
March 27, 2025
CompletedFirst Posted
Study publicly available on registry
April 3, 2025
CompletedApril 3, 2025
March 1, 2025
5 months
March 27, 2025
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Circulating beta-hydroxybutyrate
Circulating beta-hydroxybutyrate levels measured by ketone meters and GC/MS
30 minutes after consuming the drink
Circulating acetoacetate levels
30 minutes after consuming the drink
Study Arms (2)
Placebo drink
PLACEBO COMPARATORThey were provided a placebo drink that was color, calorie and flavor-matched to the experimental drink.
Experimental supplement
EXPERIMENTALThey were provided an ketone salt drink.
Interventions
Exogenous ketone salt supplement will be taken once to determine acute circulating levels of beta-hydroxybuyrate and acetoacetate compared to a control supplement.
Participants consumed a placebo drink that was flavor, color and calorie matched to the experimental drink.
Eligibility Criteria
You may qualify if:
- years
You may not qualify if:
- taking medications that affect blood pressure, insulin, or renal function, having meta-bolic syndrome factors such as type 2 diabetes, being pregnant, and/or indicating a pre-existing health condition on the health history questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Augusta University
Augusta, Georgia, 30909, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2025
First Posted
April 3, 2025
Study Start
January 15, 2019
Primary Completion
May 30, 2019
Study Completion
December 15, 2019
Last Updated
April 3, 2025
Record last verified: 2025-03